Evidence map›Paper›PMID 27784314›Full record

ArticleDiagnostic pathology2016

Quality of sweat test (ST) based on the proportion of sweat sodium (Na) and sweat chloride (Cl) as diagnostic parameter of cystic fibrosis: are we on the right way?

Alethéa Guimarães Faria, Fernando Augusto Lima Marson, Carla Cristina de Souza Gomez, Maria Ângela Gonçalves de Oliveira Ribeiro, Lucas Brioschi Morais, Maria de Fátima Servidoni, Carmen Sílvia Bertuzzo, Eulália Sakano, Maura Goto, Ilma Aparecida Paschoal and 10 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Diagnostic pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Observational
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Alethéa Guimarães FariaDepartment of Pediatrics, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Fernando Augusto Lima MarsonDepartment of Pediatrics, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil. fernandolimamarson@hotmail.com.
Carla Cristina de Souza GomezDepartment of Pediatrics, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Maria Ângela Gonçalves de Oliveira RibeiroDepartment of Pediatrics, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Lucas Brioschi MoraisDepartment of Pediatrics, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Maria de Fátima ServidoniDepartment of Pediatrics, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Carmen Sílvia BertuzzoDepartment of Medical Genetics, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Eulália SakanoDepartment of Otorhinolaryngology, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Maura GotoDepartment of Pediatrics, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Ilma Aparecida PaschoalDepartment of Clinical Medicine, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Mônica Corso PereiraDepartment of Clinical Medicine, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Gabriel HesselDepartment of Pediatrics, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Carlos Emílio LevyDepartment of Clinical Pathology, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Adyléia Aparecida Dalbo Contrera ToroDepartment of Pediatrics, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Andressa Oliveira PeixotoDepartment of Pediatrics, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Maria Cristina Ribeiro SimõesDepartment of Pediatrics, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Elizete Aparecida LomaziDepartment of Pediatrics, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Roberto José Negrão NogueiraDepartment of Pediatrics, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Antônio Fernando RibeiroDepartment of Pediatrics, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
José Dirceu RibeiroDepartment of Pediatrics, Faculty of Medical Sciences, University of Campinas, Campinas, Brazil.
Universidade Estadual de Campinas (UNICAMP) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo assess the quality of sweat test (ST) based on the proportion of sweat sodium and sweat chloride as diagnostic parameter of cystic fibrosis (CF).

methodsA retrospective study of 5,721 sweat samples and subsequent descriptive analysis were carried out. The test was considered "of good quality" (correct) when: (i) sweat chloride was lower than 60 mEq/L, and sweat sodium was higher than sweat chloride; (ii) sweat chloride was higher than 60 mEq/L, and sweat sodium was lower than sweat chloride.

resultsThe study included 5,692/5,721 sweat samples of ST which had been requested due to clinical presentations compatible with CF and/or neonatal screenings with altered immunoreactive trypsinogen values. Considering the proportion of sweat sodium and sweat chloride as ST quality parameter, the test was performed correctly in 5,023/5,692 (88.2 %) sweat samples. The sweat chloride test results were grouped into four reference ranges for chloride (i) chloride < 30 mEq/L: 3,651/5,692 (64.1 %); (ii) chloride ≥ 30 mEq/L to < 40 mEq/L: 652/5,692 (11.5 %); (iii) ≥ 40 mEq/L to < 60 mEq/L: 673/5,692 (11.8 %); (iv) ≥ 60 mEq/L: 716/5,692 (12.6 %). In the comparative analysis, there was no association between ST quality and: (i) symptoms to indicate a ST [respiratory (p = 0.084), digestive (p = 0.753), nutritional (p = 0.824), and others (p = 0.136)], (ii) sweat weight (p = 0.416). However, there was a positive association with: (i) gender, (ii) results of ST (p < 0.001), (iii) chloride/sodium ratio (p < 0.001), (iv) subject's age at the time of ST [grouped according to category (p < 0.001) and numerical order (p < 0.001)]. For the subset of 169 patients with CF and two CFTR mutations Class I, II and/or III, in comparative analysis, there was a positive association with: (i) sweat chloride/sodium ratio (p < 0.001), (ii) sweat chloride values (p = 0.047), (iii) subject's age at the time of the ST grouped by numerical order (p = 0.001).

conclusionsConsidering that the quality of ST can be assessed by levels of sweat sodium and sweat chloride, an increasing number of low-quality tests could be observed in our sweat samples. The quality of the test was associated with important factors, such as gender, CF diagnosis, and subjects' age.

Indexed as

AdolescentAdultAgedAged, 80 and overChildChild, PreschoolChloridesCystic FibrosisFemaleHumansInfantInfant, NewbornMaleMiddle AgedRetrospective StudiesSodiumChloridesSodiumCystic fibrosisDiagnosisElectrolytesSweat

Identifiers

PMID27784314
PMCPMC5080702
OpenAlexW4239453938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.